Skip to main content

Relmada Therapeutics, Inc.

RLMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001553643

In the last 90 days, Relmada Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $693.7M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Relmada Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
2 filings
2 insiders, $1.67M in total
Open-market sells
0 filings
Insiders trading
2
Net value
+$1.67M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Relmada Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Relmada Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Shenouda MagedChief Financial Officer1,000,000Sep 11, 20263
Traversa SergioChief Executive Officer1,500,000Sep 11, 20263
Casamento Charles JDirector0Dec 16, 20251
Glasspool JohnDirector–Dec 16, 20251
Kelly Paul EdwardCOO502,295Dec 16, 20252
Ence ChuckCA and CO403,931Dec 16, 20252
Fedeli FabianaDirector–Dec 16, 20251
Schmidt Eric ThomasDirector–May 30, 20230
O'Gorman CedricChief Medical Officer10,121May 24, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 11, 2026 (view filing)7:30 AM ETSep 9-102 daysShenouda MagedChief Financial OfficerPPurchase+200.0K$4.22+$844.0K+25.0%1.00M after2 lots
Sep 11, 2026 (view filing)7:30 AM ETSep 9-102 daysTraversa SergioChief Executive OfficerPPurchase+200.0K$4.14+$828.0K+15.4%1.50M after2 lots
Dec 16, 2025 (view filing)Dec 151 dayTraversa SergioChief Executive OfficerPPurchase+27.5K$4.12+$113.3K+2.2%1.30M after
Dec 16, 2025 (view filing)Dec 151 dayShenouda MagedChief Financial OfficerPPurchase+11.7K$4.12+$48.1K+1.5%800.0K after
Nov 6, 2025 (view filing)Nov 51 dayEnce ChuckCAO and COOPPurchase+136.0K$2.20+$299.2K+50.8%403.9K after
Nov 6, 2025 (view filing)Nov 51 dayTraversa SergioChief Executive OfficerPPurchase+272.5K$2.20+$599.5K+27.3%1.27M after
Nov 6, 2025 (view filing)Nov 51 dayShenouda MagedChief Financial OfficerPPurchase+500.0K$2.20+$1.10M+173.4%788.3K after
Nov 6, 2025 (view filing)Nov 51 dayKelly Paul EdwardChief Operating OfficerPPurchase+90.0K$2.20+$198.0K+21.8%502.3K after
Aug 28, 2025 (view filing)Aug 26-282 daysTraversa SergioChief Executive OfficerPPurchase+266.0K$0.6696+$178.1K+36.2%1.00M after3 lots
May 20, 2025 (view filing)6:03 PM ETMay 164 daysKelly Paul EdwardChief Operating OfficerPPurchase+200.0K$0.4303+$86.1K+94.2%412.3K after
May 20, 2025 (view filing)6:03 PM ETMay 16-204 daysShenouda MagedChief Financial OfficerPPurchase+200.0K$0.486+$97.2K+226.4%288.3K after3 lots
May 20, 2025 (view filing)6:02 PM ETMay 164 daysEnce ChuckCA and COPPurchase+229.0K$0.4513+$103.3K+587.5%267.9K after
May 20, 2025 (view filing)6:01 PM ETMay 16-204 daysTraversa SergioChief Executive OfficerPPurchase+350.0K$0.4992+$174.7K+91.1%734.0K after3 lots
Sep 11, 2024 (view filing)Sep 9-112 daysTraversa SergioChief Executive OfficerPPurchase+140.0K$2.82+$395.1K+57.4%384.0K after3 lots
Sep 11, 2024 (view filing)Sep 92 daysCasamento Charles JDirectorPPurchase+13.0K$2.56+$33.3KNew position13.0K after
Sep 11, 2024 (view filing)Sep 9-112 daysShenouda MagedChief Financial OfficerPPurchase+53.4K$2.80+$149.7K+153.1%88.3K after3 lots
Sep 11, 2024 (view filing)Sep 92 daysKelly Paul EdwardDirectorPPurchase+25.0K$2.59+$64.8K+13.3%212.3K after
Jan 31, 2024 (view filing)Jan 29-312 daysTraversa SergioChief Executive OfficerPPurchase+100.0K$3.87+$386.8K+69.4%244.0K after3 lots
Jan 31, 2024 (view filing)Jan 29-312 daysShenouda MagedChief Financial OfficerPPurchase+32.7K$3.85+$125.7K+1,466.6%34.9K after3 lots
Jan 31, 2024 (view filing)Jan 29-312 daysEnce ChuckCA and COPPurchase+39.0K$3.87+$150.9KNew position39.0K after3 lots
May 24, 2023 (view filing)May 231 dayO'Gorman CedricChief Medical OfficerPPurchase+10.0K$3.18+$31.8K+8,264.5%10.1K after
Dec 12, 2022 (view filing)Dec 84 daysTraversa SergioChief Executive OfficerPPurchase+55.3K$2.10+$116.0K+62.2%144.0K after
Jul 5, 2022 (view filing)Jun 30-Jul 15 daysTraversa SergioChief Executive OfficerSSale−29.8K$18.80−$559.6K−25.1%88.8K after5 lots
Apr 5, 2022 (view filing)Apr 41 dayKelly Paul EdwardDirectorSSale−10.0K$30.04−$300.4K−5.1%187.3K after
Apr 5, 2022 (view filing)Apr 14 daysCasamento Charles JDirectorSSale−19.8K$29.00−$574.2K−100.0%0 after6 lots
Sep 24, 2021 (view filing)Sep 222 daysCasamento Charles JDirectorSSale−6.60K$29.00−$191.4K−39.8%10.0K after3 lots
Jul 16, 2021 (view filing)Jul 151 dayCasamento Charles JDirectorSSale−3.30K$31.54−$104.1K−41.3%4.70K after2 lots